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(ITV) approach was applied. To evaluate the clinical benefit 
of DTT, the tumor motion amplitude on 4DCT was compared 
to the mean maximal peak-to-peak amplitude on fluoroscopy 
sequences acquired during DTT and the difference in PTV 
volume (DTT versus ITV) was calculated. Treatment-related 
toxicity was scored according to the Common Terminology 
Criteria for Adverse Events v.4.0. 
Results: A total of 38 lesions were treated in 35 patients. The 
delivered dose schedules were as follows: 48Gy/4 fractions 
(n=32), 51Gy/3 fractions (n= 4), 60Gy/8 fractions (n=2). Mean 
superior-inferior (SI) motion exceeded 8 mm in 14 out of 38 
lesions. DTT was used for 7 lesions. Reasons for omitting DTT 
were: pulmonary function or lesion location not allowing 
visicoil insertion and history of prior pneumothorax. Mean 
treatment time for a DTT session was 28.6 minutes (20-34.8 
minutes). Mean SI motion on 4DCT in DTT lesions was 11.8 
mm (8.6-16.9 mm). The mean maximal peak-to-peak 
amplitude observed during fluoroscopy was 20.4 mm (8.2-
50.5 mm) demonstraing a significant variability in respiration 
induced tumor motion. DTT achieved a median reduction of 
58% in PTV volume. With a median follow-up of 7 months (3-
19 months), 1 local failure was observed in a centrally 
located lesion treated with an ITV approach. Only 1 patient 
experienced a grade 2 radiation pneumonitis and 2 patients 
presented with a COPD exacerbation in the weeks following 
radiation. No toxicity was observed in the patients treated 
with DTT. 
Conclusions: DTT with the Vero4DRT system using a single 
fiducial marker proved to be clinically feasible and safe. DTT 
can be performed in an acceptable time frame, is able to 
account for respiratory variability and results in a substantial 
reduction in PTV volume.  
(1) Matsuo Y, Ueki N, Takayama K, et al. Evaluation of 
dynamic tumour tracking radiotherapy with real-time 
monitoring for lung tumours using a gimbal mounted linac. 
Radiother Oncol 2014.  
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Purpose/Objective: Background: During the last decade, 
several studies have established predictive models for normal 
tissue radiosensitivity based on multiple SNPs (1-8). 
Typically, these studies assessed a limited number of SNPs. 
For some of these SNPs, a ‘risk allele’ was defined and the 
studies then looked for an association between the total 
number of risk alleles and normal tissue complication risk. 
Even though many of these models have yielded highly 
significant results, the models have often been inconsistent 
with each other (table 1). This probably relates to the way 
these models were constructed. The process had three steps: 
1) For each of the included SNPs, a risk allele (minority vs. 
majority allele) was defined based on the observation that it 
was (often non-significantly) associated with the outcome 
parameter of the study (radiosensitivity). 2) A model was 
established based on these risk alleles. 3) A statistical test 
was carried out to determine if the number of risk alleles was 
significantly associated with radiosensitivity (the same 
parameter as used for the selection of the risk alleles). By 
doing so, a circularity is introduced into the analysis that 
makes it likely that random fluctuations (for the individual 
SNPs) are amplified into significant associations (for the 
entire model). 
Materials and Methods: In order to further explore this 
potential problem, we reanalyzed the dataset originally used 
to establish the multiple SNP model published by Andreassen 
et al. in 2003 (1). Instead of the actual SNP genotypes we 
randomly assigned ‘genotypes’ to the patients for 7 fictitious 
SNPs that had the same relative distribution as the SNPs in 
the original dataset. Subsequently, we selected risk alleles 
for these ‘SNPs’ and established a multiple SNP model 
exactly as in the original study. This procedure was repeated 
10 times.  
Results: In 8 out of 10 times a significant result was found for 
the model. This clearly demonstrates that the process of 
actively fitting the model to the dataset is indeed per se 
capable of producing nominally significant results for the 
entire model. 
Conclusions: Great caution should be taken when a 
predictive model is established and tested within the same 
patient cohort. A significant finding for a multiple SNP model 
established in this way cannot be used to indirectly validate 
the underlying SNPs. Thus, we have to establish robust 
associations for the individual SNPs that can be entered into 
a predictive multiple SNP model that should finally be 
validated in an independent dataset. 
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Purpose/Objective: Rectal bleeding is one of the common 
radiation-induced complications following radiotherapy in 
prostate cancer patients, which can greatly impair the 
quality of life for cancer survivors. The purpose of this study 
was to investigate whether single nucleotide polymorphisms 
(SNPs) are associated with susceptibility to late rectal 
bleeding in men treated with radiotherapy for prostate 
cancer using a genome-wide association study (GWAS) 
dataset. 
